Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
企業コードNSRX
会社名Nasus Pharma Ltd
上場日Aug 13, 2025
最高経営責任者「CEO」Teleman (Dan)
従業員数- -
証券種類Ordinary Share
決算期末Aug 13
本社所在地Yigal Alon 65
都市TEL AVIV-YAFO
証券取引所NASDAQ OMX – NASDAQ Basic Amex
国Israel
郵便番号- -
電話番号97237326616
ウェブサイトhttps://www.nasuspharma.com
企業コードNSRX
上場日Aug 13, 2025
最高経営責任者「CEO」Teleman (Dan)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし